Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1544
-
Total 13F shares, excl. options
-
999,239,167
-
Shares change
-
+9,855,729
-
Total reported value, excl. options
-
$69,763,198,043
-
Value change
-
+$691,955,339
-
Put/Call ratio
-
1.08%
-
Number of buys
-
710
-
Number of sells
-
-673
-
Price
-
$69.85
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2021
1,718 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2021.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,544 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 999,239,167 shares
of 1,240,722,841 outstanding shares and own 80.54% of the company stock.
Largest 10 shareholders include BlackRock Inc. (120,982,349 shares), Capital Research Global Investors (114,548,108 shares), VANGUARD GROUP INC (105,205,361 shares), STATE STREET CORP (55,182,125 shares), Capital International Investors (39,450,160 shares), Dodge & Cox (37,266,692 shares), Capital World Investors (36,976,309 shares), GEODE CAPITAL MANAGEMENT, LLC (22,298,484 shares), MORGAN STANLEY (15,399,628 shares), and NORTHERN TRUST CORP (14,477,966 shares).
This table shows the top 1544 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.